Overview
Tiejun Qin practices in Tianjin, China. Qin is rated as an Advanced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Their top areas of expertise are Myelodysplastic Syndrome (MDS), Myelofibrosis, Polycythemia Vera, and Hypereosinophilic Syndrome.
Their clinical research consists of co-authoring 112 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Myelodysplastic Syndrome (MDS)
- MyelofibrosisQin isDistinguished. Learn about Myelofibrosis.
- Advanced
- Essential Thrombocythemia
- Hypereosinophilic Syndrome
- Myeloproliferative Neoplasms (MPN)
- Philadelphia-Negative Chronic Myeloid Leukemia
- Polycythemia VeraQin isAdvanced. Learn about Polycythemia Vera.
- SplenomegalyQin isAdvanced. Learn about Splenomegaly.
- Experienced
- Acute Myeloid Leukemia (AML)
- ADULT SyndromeQin isExperienced. Learn about ADULT Syndrome.
- AnemiaQin isExperienced. Learn about Anemia.
- Blood ClotsQin isExperienced. Learn about Blood Clots.
- Chromosome 7p DeletionQin isExperienced. Learn about Chromosome 7p Deletion.
- Chronic Myelomonocytic Leukemia (CMML)